AEGR
Aegerion Pharmaceuticals
AEGR
AEGR
Delisted
AEGR was delisted on the 29th of November, 2016.
131 hedge funds and large institutions have $1.24B invested in Aegerion Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 50 increasing their positions, 29 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 32
39% less call options, than puts
Call options by funds: $32M | Put options by funds: $52.3M
Holders
131
Holding in Top 10
4
Calls
$32M
Puts
$52.3M
Top Buyers
| 1 | +$70.9M | |
| 2 | +$19.6M | |
| 3 | +$16.8M | |
| 4 |
HM
HealthCor Management
New York
|
+$15.5M |
| 5 |
Morgan Stanley
New York
|
+$14.9M |
Top Sellers
| 1 | -$40.9M | |
| 2 | -$13.3M | |
| 3 | -$11.7M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$10.8M |
| 5 |
FAM
Fred Alger Management
New York
|
-$6.46M |